Arq vs ASP Isotopes
ARQ and ASPI side by side, both in chemicals and allied products. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How ARQ and ASPI compare
ASP Isotopes is the larger company, worth 1.6 times as much as Arq ($210M against $133M).
ASP Isotopes grew revenue faster over the last twelve months (573% versus 4.9% for Arq).
Arq keeps more of each dollar of sales as profit, with a net margin of −42.6% compared with −380% at ASP Isotopes.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | ARQ | ASPI |
|---|---|---|
| Size and price | ||
| Market cap | $133M | $210M |
| Share price | $3.04 | $1.37 |
| Change, 1 year | −13.9% | −83.1% |
| Change, 5 years | −54.0% | – |
| Beta (5Y) | 0.99 | 3.00 |
| Employees | 202 | 271 |
| StockData Score | ||
| Total score | 6 | 6 |
| Valuation score | 3 | 3 |
| Growth score | 0 | 1 (better) |
| Performance score | 0 | 0 |
| Health score | 3 (better) | 2 |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/S | 1.1× (better) | 6.8× |
| P/B | 0.8× (better) | 0.8× |
| FCF yield | −3.8% (better) | −39.8% |
| Fair value | $4.94 | $5.20 |
| Margin of safety | 38.4% | 73.7% (better) |
| Growth | ||
| Revenue growth (TTM) | 4.9% | 573% (better) |
| Revenue growth, 5Y average | 12.3% | – |
| Profitability | ||
| Gross margin | 28.8% (better) | 18.3% |
| Operating margin | −43.0% (better) | −321% |
| Net margin | −42.6% (better) | −380% |
| FCF margin | −4.1% (better) | −271% |
| Return on equity | −27.2% (better) | −80.9% |
| Return on invested capital | −19.6% (better) | −549% |
| Financial health | ||
| Debt / equity | 0.18 (better) | 0.23 |
| Interest coverage | −20.6× (better) | −25.3× |
| Current ratio | 1.03 | 3.87 (better) |
| Altman Z-score | 1.09 (better) | −0.34 |
| Piotroski F-score | 1 | 4 (better) |
| Dividends and buybacks | ||
| Shareholder yield | 0.00% | 0.00% |
| Ownership | ||
| Held by institutions | 35.5% | 42.7% |
| Held by insiders | 21.1% | 10.7% |
| Insider net buying, 12 months | $524K (better) | −$7.7M |
| Short interest, % of float | 1.4% | 22.9% |
Go deeper
- ARQ stock overview
- ARQ income statement
- ARQ valuation and score
- ASPI stock overview
- ASPI income statement
- ASPI valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.